PT Pyridam Farma Tbk

Rp 118.00As of Sun 8 Nov 2026, 12:00 UTC
IDX:PYFAHealthcare
Country Indonesia
PE (Fwd) •••
TSR 10Y CAGR 13.64%
Div yield —
ROE (47.21%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.00
PE TTM —
TSR TTM (77.31%)
Mkt cap Rp 1.326T
ROIC (0.50%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
Rp 114
(3.72%)
(67.77%)
Hold 4|7|5|2|9
4Q25
1Q26
2Q26
3Q26
Earnings per shareRp
1.79
1.95
1.93
1.87
15.21%
12.89%
9.08%
10.73%
RevenueRp B
70.22
70.67
68.81
70.55
11.72%
8.03%
0.53%
0.08%
Peers (US$73.24M)
Cap (US$)
PE
97.13M
12.36x
86.37M
6.555x
21.57M
18.12x
Capital
TTM
5Y
10Y
Leveragex
1.067
(0.135)
(0.110)
EBIT/Intx
0.869
0.610
0.560
Own earn%
5.32
(99.55)
(92.01)
Sh yield%
25.15
53.55
59.02
Owners
Insiders/Inst%
6.49
24.73
Short interest%
2.06
SBC / revenue%
5.18
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
11–16
$1 testx
0.0
Incr. ROIC%
11